{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,21]],"date-time":"2026-10-21T22:44:35Z","timestamp":1792622675760,"version":"4.5.0"},"reference-count":76,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2022,8,9]],"date-time":"2022-08-09T00:00:00Z","timestamp":1660003200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2022,8,9]],"date-time":"2022-08-09T00:00:00Z","timestamp":1660003200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/100000055","name":"National Institute on Deafness and Other Communication Disorders","doi-asserted-by":"publisher","award":["R01DC008552"],"award-info":[{"award-number":["R01DC008552"]}],"id":[{"id":"10.13039\/100000055","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000049","name":"National Institute on Aging","doi-asserted-by":"publisher","award":["P30AG013854"],"award-info":[{"award-number":["P30AG013854"]}],"id":[{"id":"10.13039\/100000049","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000049","name":"National Institute on Aging","doi-asserted-by":"publisher","award":["P30AG072977"],"award-info":[{"award-number":["P30AG072977"]}],"id":[{"id":"10.13039\/100000049","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000049","name":"National Institute on Aging","doi-asserted-by":"publisher","award":["T32AG020506"],"award-info":[{"award-number":["T32AG020506"]}],"id":[{"id":"10.13039\/100000049","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000049","name":"National Institute on Aging","doi-asserted-by":"publisher","award":["R01AG056258"],"award-info":[{"award-number":["R01AG056258"]}],"id":[{"id":"10.13039\/100000049","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000065","name":"National Institute of Neurological Disorders and Stroke","doi-asserted-by":"publisher","award":["R01NS075075"],"award-info":[{"award-number":["R01NS075075"]}],"id":[{"id":"10.13039\/100000065","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["acta neuropathol commun"],"abstract":"<jats:title>Abstract<\/jats:title><jats:p>Quantification of in vivo amyloid and tau PET imaging relationships with postmortem measurements are critical for validating the sensitivity and specificity imaging biomarkers across clinical phenotypes with Alzheimer disease neuropathologic change (ADNC). This study examined the quantitative relationship between regional binding of in vivo <jats:sup>18<\/jats:sup>F-florbetapir amyloid PET and <jats:sup>18<\/jats:sup>F-flortaucipir tau PET with postmortem stereological counts of amyloid plaques and neurofibrillary tangles (NFT) in a case of primary progressive aphasia (PPA) with ADNC, where neurodegeneration asymmetrically targets the left hemisphere. Beginning 2\u00a0years prior to death, a 63-year-old right-handed man presenting with agrammatic variant PPA underwent a florbetapir and flortaucpir PET scan, and neuropsychological assessments and magnetic resonance imaging sessions every 6\u00a0months. Florbetapir and flortaucpir PET standard uptake value ratios (SUVRs) were quantified from 8 left and right hemisphere brain regions with stereological quantification of amyloid plaques and NFTs from corresponding postmortem sections. Pearson\u2019s correlations and measures of asymmetry were used to examine relationships between imaging and autopsy measurements. The three visits prior to death revealed decline of language measures, with marked progression of atrophy. Florbetapir PET presented with an atypical focal pattern of uptake and showed a significant positive correlation with postmortem amyloid plaque density across the 8 regions (<jats:italic>r<\/jats:italic>\u2009=\u20090.92; <jats:italic>p<\/jats:italic>\u2009=\u20090.001). Flortaucipir PET had a left-lateralized distribution and showed a significant positive correlation with NFT density (<jats:italic>r<\/jats:italic>\u2009=\u20090.78; <jats:italic>p<\/jats:italic>\u2009=\u20090.023). Flortaucipir PET and NFT density indicated a medial temporal lobe sparing presentation of ADNC, demonstrating that AD does not always target the medial temporal lobe. This study adds additional evidence, in a non-amnestic phenotype of ADNC, that there is a strong correlation between AD PET biomarkers, florbetapir and flortaucipir, with quantitative neuropathology. The atypical and focal presentation of plaque density and florbetapir PET uptake suggests not all amyloid pathology presents as diffuse across neocortex.<\/jats:p>","DOI":"10.1186\/s40478-022-01412-w","type":"journal-article","created":{"date-parts":[[2022,8,9]],"date-time":"2022-08-09T10:02:52Z","timestamp":1660039372000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":10,"title":["Focal amyloid and asymmetric tau in an imaging-to-autopsy case of clinical primary progressive aphasia with Alzheimer disease neuropathology"],"prefix":"10.1186","volume":"10","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-6997-9390","authenticated-orcid":false,"given":"Adam","family":"Martersteck","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ivan","family":"Ayala","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniel T.","family":"Ohm","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Callen","family":"Spencer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christina","family":"Coventry","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sandra","family":"Weintraub","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eileen H.","family":"Bigio","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M. -Marsel","family":"Mesulam","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Changiz","family":"Geula","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Emily","family":"Rogalski","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2022,8,9]]},"reference":[{"issue":"1","key":"1412_CR1","doi-asserted-by":"publisher","first-page":"95","DOI":"10.1016\/j.neuroimage.2007.07.007","volume":"38","author":"J Ashburner","year":"2007","unstructured":"Ashburner J (2007) A fast diffeomorphic image registration algorithm. Neuroimage 38(1):95\u2013113","journal-title":"Neuroimage"},{"key":"1412_CR2","doi-asserted-by":"publisher","first-page":"648","DOI":"10.1016\/j.dib.2017.10.024","volume":"15","author":"SL Baker","year":"2017","unstructured":"Baker SL, Maass A, Jagust WJ (2017) Considerations and code for partial volume correcting [(18)F]-AV-1451 tau PET data. Data Brief 15:648\u2013657","journal-title":"Data Brief"},{"issue":"4","key":"1412_CR3","doi-asserted-by":"publisher","first-page":"1509","DOI":"10.3233\/JAD-170762","volume":"61","author":"TG Beach","year":"2018","unstructured":"Beach TG, Maarouf CL, Intorcia A, Sue LI, Serrano GE, Lu M et al (2018) Antemortem-Postmortem Correlation of Florbetapir (18F) PET Amyloid Imaging with Quantitative Biochemical Measures of Abeta42 but not Abeta40. J Alzheimers Dis 61(4):1509\u20131516","journal-title":"J Alzheimers Dis"},{"key":"1412_CR4","doi-asserted-by":"publisher","first-page":"450","DOI":"10.1016\/j.neuroimage.2014.11.055","volume":"108","author":"M Brendel","year":"2015","unstructured":"Brendel M, Hogenauer M, Delker A, Sauerbeck J, Bartenstein P, Seibyl J et al (2015) Improved longitudinal [(18)F]-AV45 amyloid PET by white matter reference and VOI-based partial volume effect correction. Neuroimage 108:450\u2013459","journal-title":"Neuroimage"},{"issue":"11","key":"1412_CR5","doi-asserted-by":"publisher","first-page":"1887","DOI":"10.2967\/jnumed.109.065284","volume":"50","author":"SR Choi","year":"2009","unstructured":"Choi SR, Golding G, Zhuang Z, Zhang W, Lim N, Hefti F et al (2009) Preclinical properties of 18F-AV-45: a PET agent for Abeta plaques in the brain. J Nucl Med 50(11):1887\u20131894","journal-title":"J Nucl Med"},{"issue":"3","key":"1412_CR6","doi-asserted-by":"publisher","first-page":"275","DOI":"10.1001\/jama.2010.2008","volume":"305","author":"CM Clark","year":"2011","unstructured":"Clark CM, Schneider JA, Bedell BJ, Beach TG, Bilker WB, Mintun MA et al (2011) Use of florbetapir-PET for imaging beta-amyloid pathology. JAMA 305(3):275\u2013283","journal-title":"JAMA"},{"issue":"8","key":"1412_CR7","doi-asserted-by":"publisher","first-page":"669","DOI":"10.1016\/S1474-4422(12)70142-4","volume":"11","author":"CM Clark","year":"2012","unstructured":"Clark CM, Pontecorvo MJ, Beach TG, Bedell BJ, Coleman RE, Doraiswamy PM et al (2012) Cerebral PET with florbetapir compared with neuropathology at autopsy for detection of neuritic amyloid-beta plaques: a prospective cohort study. Lancet Neurol 11(8):669\u2013678","journal-title":"Lancet Neurol"},{"issue":"3","key":"1412_CR8","doi-asserted-by":"publisher","first-page":"287","DOI":"10.1001\/jamaneurol.2014.4144","volume":"72","author":"C Curtis","year":"2015","unstructured":"Curtis C, Gamez JE, Singh U, Sadowsky CH, Villena T, Sabbagh MN et al (2015) Phase 3 trial of flutemetamol labeled with radioactive fluorine 18 imaging and neuritic plaque density. JAMA Neurol 72(3):287\u2013294","journal-title":"JAMA Neurol"},{"issue":"10","key":"1412_CR9","doi-asserted-by":"publisher","first-page":"e896","DOI":"10.1212\/WNL.0000000000005064","volume":"90","author":"GS Day","year":"2018","unstructured":"Day GS, Gordon BA, Perrin RJ, Cairns NJ, Beaumont H, Schwetye K et al (2018) In vivo [(18)F]-AV-1451 tau-PET imaging in sporadic Creutzfeldt-Jakob disease. Neurology 90(10):e896\u2013e906","journal-title":"Neurology"},{"issue":"3","key":"1412_CR10","doi-asserted-by":"publisher","first-page":"1786","DOI":"10.1016\/j.neuroimage.2010.10.035","volume":"54","author":"J Diedrichsen","year":"2011","unstructured":"Diedrichsen J, Maderwald S, Kuper M, Thurling M, Rabe K, Gizewski ER et al (2011) Imaging the deep cerebellar nuclei: a probabilistic atlas and normalization procedure. Neuroimage 54(3):1786\u20131794","journal-title":"Neuroimage"},{"key":"1412_CR11","doi-asserted-by":"crossref","unstructured":"Dunn LMD, Douglas M., Peabody Picture Vocabulary Test. 2007, Pearson Assessments: Toronto.","DOI":"10.1037\/t15144-000"},{"issue":"11","key":"1412_CR12","doi-asserted-by":"publisher","first-page":"1404","DOI":"10.1001\/archneurol.2011.150","volume":"68","author":"AS Fleisher","year":"2011","unstructured":"Fleisher AS, Chen K, Liu X, Roontiva A, Thiyyagura P, Ayutyanont N et al (2011) Using positron emission tomography and florbetapir F18 to image cortical amyloid in patients with mild cognitive impairment or dementia due to Alzheimer disease. Arch Neurol 68(11):1404\u20131411","journal-title":"Arch Neurol"},{"issue":"7","key":"1412_CR13","doi-asserted-by":"publisher","first-page":"829","DOI":"10.1001\/jamaneurol.2020.0528","volume":"77","author":"AS Fleisher","year":"2020","unstructured":"Fleisher AS, Pontecorvo MJ, Devous MD Sr, Lu M, Arora AK, Truocchio SP et al (2020) Positron emission tomography imaging with [18F]flortaucipir and postmortem assessment of Alzheimer disease neuropathologic changes. JAMA Neurol 77(7):829\u2013839","journal-title":"JAMA Neurol"},{"issue":"Pt 5","key":"1412_CR14","doi-asserted-by":"publisher","first-page":"1554","DOI":"10.1093\/brain\/aws076","volume":"135","author":"T Gefen","year":"2012","unstructured":"Gefen T, Gasho K, Rademaker A, Lalehzari M, Weintraub S, Rogalski E et al (2012) Clinically concordant variations of Alzheimer pathology in aphasic versus amnestic dementia. Brain 135(Pt 5):1554\u20131565","journal-title":"Brain"},{"issue":"5","key":"1412_CR15","doi-asserted-by":"publisher","first-page":"1009","DOI":"10.1002\/ana.25893","volume":"88","author":"A Ghirelli","year":"2020","unstructured":"Ghirelli A, Tosakulwong N, Weigand SD, Clark HM, Ali F, Botha H et al (2020) Sensitivity-specificity of Tau and Amyloid beta positron emission tomography in frontotemporal lobar degeneration. Ann Neurol 88(5):1009\u20131022","journal-title":"Ann Neurol"},{"issue":"11","key":"1412_CR16","doi-asserted-by":"publisher","first-page":"1006","DOI":"10.1212\/WNL.0b013e31821103e6","volume":"76","author":"ML Gorno-Tempini","year":"2011","unstructured":"Gorno-Tempini ML, Hillis AE, Weintraub S, Kertesz A, Mendez M, Cappa SF et al (2011) Classification of primary progressive aphasia and its variants. Neurology 76(11):1006\u20131014","journal-title":"Neurology"},{"key":"1412_CR17","doi-asserted-by":"crossref","unstructured":"Greve DN, Svarer C, Fisher PM, Feng L, Hansen AE, Baare W, et al., Cortical surface-based analysis reduces bias and variance in kinetic modeling of brain PET data. Neuroimage, 2013.","DOI":"10.1016\/j.neuroimage.2013.12.021"},{"key":"1412_CR18","doi-asserted-by":"publisher","first-page":"334","DOI":"10.1016\/j.neuroimage.2016.02.042","volume":"132","author":"DN Greve","year":"2016","unstructured":"Greve DN, Salat DH, Bowen SL, Izquierdo-Garcia D, Schultz AP, Catana C et al (2016) Different partial volume correction methods lead to different conclusions: An F-FDG-PET study of aging. Neuroimage 132:334\u2013343","journal-title":"Neuroimage"},{"issue":"1","key":"1412_CR19","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.jalz.2011.10.007","volume":"8","author":"BT Hyman","year":"2012","unstructured":"Hyman BT, Phelps CH, Beach TG, Bigio EH, Cairns NJ, Carrillo MC et al (2012) National Institute on Aging-Alzheimer\u2019s Association guidelines for the neuropathologic assessment of Alzheimer\u2019s disease. Alzheimers & Dementia 8(1):1\u201313","journal-title":"Alzheimers & Dementia"},{"issue":"1","key":"1412_CR20","doi-asserted-by":"publisher","first-page":"130","DOI":"10.1186\/s40478-016-0399-z","volume":"4","author":"MD Ikonomovic","year":"2016","unstructured":"Ikonomovic MD, Buckley CJ, Heurling K, Sherwin P, Jones PA, Zanette M et al (2016) Post-mortem histopathology underlying beta-amyloid PET imaging following flutemetamol F 18 injection. Acta Neuropathol Commun 4(1):130","journal-title":"Acta Neuropathol Commun"},{"issue":"4","key":"1412_CR21","doi-asserted-by":"publisher","first-page":"463","DOI":"10.1007\/s00401-020-02175-1","volume":"140","author":"MD Ikonomovic","year":"2020","unstructured":"Ikonomovic MD, Buckley CJ, Abrahamson EE, Kofler JK, Mathis CA, Klunk WE et al (2020) Post-mortem analyses of PiB and flutemetamol in diffuse and cored amyloid-beta plaques in Alzheimer\u2019s disease. Acta Neuropathol 140(4):463\u2013476","journal-title":"Acta Neuropathol"},{"issue":"3","key":"1412_CR22","doi-asserted-by":"publisher","first-page":"633","DOI":"10.1109\/TNS.2009.2015764","volume":"56","author":"BW Jakoby","year":"2009","unstructured":"Jakoby BW, Bercier Y, Watson CC, Bendriem B, Townsend DW (2009) Performance characteristics of a new LSO PET\/CT scanner with extended axial field-of-view and PSF reconstruction. IEEE Trans Nucl Sci 56(3):633\u2013639","journal-title":"IEEE Trans Nucl Sci"},{"issue":"6","key":"1412_CR23","doi-asserted-by":"publisher","first-page":"931","DOI":"10.1007\/s00401-016-1618-1","volume":"132","author":"KA Josephs","year":"2016","unstructured":"Josephs KA, Whitwell JL, Tacik P, Duffy JR, Senjem ML, Tosakulwong N et al (2016) [18F]AV-1451 tau-PET uptake does correlate with quantitatively measured 4R-tau burden in autopsy-confirmed corticobasal degeneration. Acta Neuropathol 132(6):931\u2013933","journal-title":"Acta Neuropathol"},{"key":"1412_CR24","unstructured":"Kaplan E, Goodglass H and Weintraub S, Boston naming test. 1983, Lea & Febiger: Philadelphia. p. [4] p., 60 leaves of ill."},{"key":"1412_CR25","unstructured":"Kertesz A, Western Aphasia Battery. 1982, The Psychological Corporation."},{"issue":"1","key":"1412_CR26","first-page":"27","volume":"30","author":"YS Lee","year":"2015","unstructured":"Lee YS, Kim JS, Kim JY, Kim BI, Lim SM, Kim HJ (2015) Spatial resolution and image qualities of Zr-89 on Siemens Biograph TruePoint PET\/CT. Cancer Biother Radiopharm 30(1):27\u201332","journal-title":"Cancer Biother Radiopharm"},{"key":"1412_CR27","doi-asserted-by":"publisher","first-page":"46","DOI":"10.1186\/2051-5960-2-46","volume":"2","author":"V Leinonen","year":"2014","unstructured":"Leinonen V, Rinne JO, Wong DF, Wolk DA, Trojanowski JQ, Sherwin PF et al (2014) Diagnostic effectiveness of quantitative [(1)(8)F]flutemetamol PET imaging for detection of fibrillar amyloid beta using cortical biopsy histopathology as the standard of truth in subjects with idiopathic normal pressure hydrocephalus. Acta Neuropathol Commun 2:46","journal-title":"Acta Neuropathol Commun"},{"issue":"Pt 10","key":"1412_CR28","doi-asserted-by":"publisher","first-page":"3030","DOI":"10.1093\/brain\/awr216","volume":"134","author":"CE Leyton","year":"2011","unstructured":"Leyton CE, Villemagne VL, Savage S, Pike KE, Ballard KJ, Piguet O et al (2011) Subtypes of progressive aphasia: application of the International Consensus Criteria and validation using beta-amyloid imaging. Brain 134(Pt 10):3030\u20133043","journal-title":"Brain"},{"issue":"1","key":"1412_CR29","doi-asserted-by":"publisher","first-page":"58","DOI":"10.1186\/s40478-016-0315-6","volume":"4","author":"VJ Lowe","year":"2016","unstructured":"Lowe VJ, Curran G, Fang P, Liesinger AM, Josephs KA, Parisi JE et al (2016) An autoradiographic evaluation of AV-1451 Tau PET in dementia. Acta Neuropathol Commun 4(1):58","journal-title":"Acta Neuropathol Commun"},{"issue":"3","key":"1412_CR30","doi-asserted-by":"publisher","first-page":"561","DOI":"10.1016\/j.jalz.2019.09.079","volume":"16","author":"VJ Lowe","year":"2020","unstructured":"Lowe VJ, Lundt ES, Albertson SM, Min HK, Fang P, Przybelski SA et al (2020) Tau-positron emission tomography correlates with neuropathology findings. Alzheimers Dement 16(3):561\u2013571","journal-title":"Alzheimers Dement"},{"issue":"4","key":"1412_CR31","doi-asserted-by":"publisher","first-page":"517","DOI":"10.1001\/jamaneurol.2019.4509","volume":"77","author":"WG Mantyh","year":"2020","unstructured":"Mantyh WG, Spina S, Lee A, Iaccarino L, Soleimani-Meigooni D, Tsoy E et al (2020) Tau positron emission tomographic findings in a former US football player with pathologically confirmed chronic traumatic encephalopathy. JAMA Neurol 77(4):517\u2013521","journal-title":"JAMA Neurol"},{"issue":"5","key":"1412_CR32","doi-asserted-by":"publisher","first-page":"787","DOI":"10.1002\/ana.24517","volume":"78","author":"M Marquie","year":"2015","unstructured":"Marquie M, Normandin MD, Vanderburg CR, Costantino IM, Bien EA, Rycyna LG et al (2015) Validating novel tau positron emission tomography tracer [F-18]-AV-1451 (T807) on postmortem brain tissue. Ann Neurol 78(5):787\u2013800","journal-title":"Ann Neurol"},{"issue":"3","key":"1412_CR33","doi-asserted-by":"publisher","first-page":"496","DOI":"10.1002\/ana.24566","volume":"79","author":"A Martersteck","year":"2016","unstructured":"Martersteck A, Murphy C, Rademaker A, Wieneke C, Weintraub S, Chen K et al (2016) Is in vivo amyloid distribution asymmetric in primary progressive aphasia? Ann Neurol 79(3):496\u2013501","journal-title":"Ann Neurol"},{"issue":"11","key":"1412_CR34","doi-asserted-by":"publisher","first-page":"1788","DOI":"10.1002\/alz.12445","volume":"17","author":"A Martersteck","year":"2021","unstructured":"Martersteck A, Sridhar J, Coventry C, Weintraub S, Mesulam MM, Rogalski E (2021) Relationships among tau burden, atrophy, age, and naming in the aphasic variant of Alzheimer\u2019s disease. Alzheimers Dement 17(11):1788\u20131797","journal-title":"Alzheimers Dement"},{"issue":"18","key":"1412_CR35","doi-asserted-by":"publisher","first-page":"e1799","DOI":"10.1212\/WNL.0000000000012770","volume":"97","author":"SJ McCarter","year":"2021","unstructured":"McCarter SJ, Lesnick TG, Lowe V, Mielke MM, Constantopoulos E, Rabinstein AA et al (2021) Cerebral amyloid angiopathy pathology and its association with amyloid-beta PET signal. Neurology 97(18):e1799\u2013e1808","journal-title":"Neurology"},{"issue":"12","key":"1412_CR36","doi-asserted-by":"publisher","first-page":"1545","DOI":"10.1001\/archneurol.2009.288","volume":"66","author":"M Mesulam","year":"2009","unstructured":"Mesulam M, Wieneke C, Rogalski E, Cobia D, Thompson C, Weintraub S (2009) Quantitative template for subtyping primary progressive aphasia. Arch Neurol 66(12):1545\u20131551","journal-title":"Arch Neurol"},{"issue":"Pt 5","key":"1412_CR37","doi-asserted-by":"publisher","first-page":"1537","DOI":"10.1093\/brain\/aws080","volume":"135","author":"MM Mesulam","year":"2012","unstructured":"Mesulam MM, Wieneke C, Thompson C, Rogalski E, Weintraub S (2012) Quantitative classification of primary progressive aphasia at early and mild impairment stages. Brain 135(Pt 5):1537\u20131553","journal-title":"Brain"},{"issue":"Pt 4","key":"1412_CR38","doi-asserted-by":"publisher","first-page":"1176","DOI":"10.1093\/brain\/awu024","volume":"137","author":"MM Mesulam","year":"2014","unstructured":"Mesulam MM, Weintraub S, Rogalski EJ, Wieneke C, Geula C, Bigio EH (2014) Asymmetry and heterogeneity of Alzheimer\u2019s and frontotemporal pathology in primary progressive aphasia. Brain 137(Pt 4):1176\u20131192","journal-title":"Brain"},{"issue":"4","key":"1412_CR39","doi-asserted-by":"publisher","first-page":"479","DOI":"10.1212\/WNL.41.4.479","volume":"41","author":"SS Mirra","year":"1991","unstructured":"Mirra SS, Heyman A, McKeel D, Sumi SM, Crain BJ, Brownlee LM et al (1991) The Consortium to Establish a Registry for Alzheimer\u2019s Disease (CERAD). Part II. Standardization of the neuropathologic assessment of Alzheimer\u2019s disease. Neurology 41(4):479\u2013486","journal-title":"Neurology"},{"issue":"1","key":"1412_CR40","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1007\/s00401-011-0910-3","volume":"123","author":"TJ Montine","year":"2012","unstructured":"Montine TJ, Phelps CH, Beach TG, Bigio EH, Cairns NJ, Dickson DW et al (2012) National Institute on Aging-Alzheimer\u2019s Association guidelines for the neuropathologic assessment of Alzheimer\u2019s disease: a practical approach. Acta Neuropathol 123(1):1\u201311","journal-title":"Acta Neuropathol"},{"issue":"9","key":"1412_CR41","doi-asserted-by":"publisher","first-page":"785","DOI":"10.1016\/S1474-4422(11)70156-9","volume":"10","author":"ME Murray","year":"2011","unstructured":"Murray ME, Graff-Radford NR, Ross OA, Petersen RC, Duara R, Dickson DW (2011) Neuropathologically defined subtypes of Alzheimer\u2019s disease with distinct clinical characteristics: a retrospective study. Lancet Neurol 10(9):785\u2013796","journal-title":"Lancet Neurol"},{"issue":"8","key":"1412_CR42","doi-asserted-by":"publisher","first-page":"1140","DOI":"10.1001\/archneur.64.8.1140","volume":"64","author":"SY Ng","year":"2007","unstructured":"Ng SY, Villemagne VL, Masters CL, Rowe CC (2007) Evaluating atypical dementia syndromes using positron emission tomography with carbon 11 labeled Pittsburgh Compound B. Arch Neurol 64(8):1140\u20131144","journal-title":"Arch Neurol"},{"issue":"2","key":"1412_CR43","doi-asserted-by":"publisher","first-page":"332","DOI":"10.1111\/bpa.12783","volume":"30","author":"DT Ohm","year":"2020","unstructured":"Ohm DT, Fought AJ, Rademaker A, Kim G, Sridhar J, Coventry C et al (2020) Neuropathologic basis of in vivo cortical atrophy in the aphasic variant of Alzheimer\u2019s disease. Brain Pathol 30(2):332\u2013344","journal-title":"Brain Pathol"},{"issue":"1","key":"1412_CR44","doi-asserted-by":"publisher","first-page":"189","DOI":"10.1111\/bpa.12902","volume":"31","author":"DT Ohm","year":"2021","unstructured":"Ohm DT, Fought AJ, Martersteck A, Coventry C, Sridhar J, Gefen T et al (2021) Accumulation of neurofibrillary tangles and activated microglia is associated with lower neuron densities in the aphasic variant of Alzheimer\u2019s disease. Brain Pathol 31(1):189\u2013204","journal-title":"Brain Pathol"},{"issue":"1","key":"1412_CR45","doi-asserted-by":"publisher","first-page":"97","DOI":"10.1016\/0028-3932(71)90067-4","volume":"9","author":"RC Oldfield","year":"1971","unstructured":"Oldfield RC (1971) The assessment and analysis of handedness: the Edinburgh inventory. Neuropsychologia 9(1):97\u2013113","journal-title":"Neuropsychologia"},{"issue":"Pt 5","key":"1412_CR46","doi-asserted-by":"publisher","first-page":"1551","DOI":"10.1093\/brain\/aww027","volume":"139","author":"R Ossenkoppele","year":"2016","unstructured":"Ossenkoppele R, Schonhaut DR, Scholl M, Lockhart SN, Ayakta N, Baker SL et al (2016) Tau PET patterns mirror clinical and neuroanatomical variability in Alzheimer\u2019s disease. Brain 139(Pt 5):1551\u20131567","journal-title":"Brain"},{"issue":"4","key":"1412_CR47","doi-asserted-by":"publisher","first-page":"597","DOI":"10.1007\/s00401-019-02036-6","volume":"138","author":"C Petersen","year":"2019","unstructured":"Petersen C, Nolan AL, de Paula Franca Resende E, Miller Z, Ehrenberg AJ, Gorno-Tempini ML et al (2019) Alzheimer\u2019s disease clinical variants show distinct regional patterns of neurofibrillary tangle accumulation. Acta Neuropathol 138(4):597\u2013612","journal-title":"Acta Neuropathol"},{"issue":"1","key":"1412_CR48","doi-asserted-by":"publisher","first-page":"65","DOI":"10.1186\/s13550-020-00653-x","volume":"10","author":"MJ Pontecorvo","year":"2020","unstructured":"Pontecorvo MJ, Keene CD, Beach TG, Montine TJ, Arora AK, Devous MD Sr et al (2020) Comparison of regional flortaucipir PET with quantitative tau immunohistochemistry in three subjects with Alzheimer\u2019s disease pathology: a clinicopathological study. EJNMMI Res 10(1):65","journal-title":"EJNMMI Res"},{"issue":"4","key":"1412_CR49","doi-asserted-by":"publisher","first-page":"388","DOI":"10.1002\/ana.21451","volume":"64","author":"GD Rabinovici","year":"2008","unstructured":"Rabinovici GD, Jagust WJ, Furst AJ, Ogar JM, Racine CA, Mormino EC et al (2008) Abeta amyloid and glucose metabolism in three variants of primary progressive aphasia. Ann Neurol 64(4):388\u2013401","journal-title":"Ann Neurol"},{"issue":"4","key":"1412_CR50","doi-asserted-by":"publisher","first-page":"1181","DOI":"10.1016\/j.neuroimage.2010.07.020","volume":"53","author":"M Reuter","year":"2010","unstructured":"Reuter M, Rosas HD, Fischl B (2010) Highly accurate inverse consistent registration: a robust approach. Neuroimage 53(4):1181\u20131196","journal-title":"Neuroimage"},{"issue":"1","key":"1412_CR51","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1016\/j.neuroimage.2011.02.076","volume":"57","author":"M Reuter","year":"2011","unstructured":"Reuter M, Fischl B (2011) Avoiding asymmetry-induced bias in longitudinal image processing. Neuroimage 57(1):19\u201321","journal-title":"Neuroimage"},{"issue":"4","key":"1412_CR52","doi-asserted-by":"publisher","first-page":"237","DOI":"10.1159\/000355256","volume":"13","author":"JO Rinne","year":"2014","unstructured":"Rinne JO, Frantzen J, Leinonen V, Lonnrot K, Laakso A, Virtanen KA et al (2014) Prospective flutemetamol positron emission tomography and histopathology in normal pressure hydrocephalus. Neurodegener Dis 13(4):237\u2013245","journal-title":"Neurodegener Dis"},{"issue":"13","key":"1412_CR53","doi-asserted-by":"publisher","first-page":"1184","DOI":"10.1212\/WNL.0000000000000824","volume":"83","author":"E Rogalski","year":"2014","unstructured":"Rogalski E, Cobia D, Martersteck A, Rademaker A, Wieneke C, Weintraub S et al (2014) Asymmetry of cortical decline in subtypes of primary progressive aphasia. Neurology 83(13):1184\u20131191","journal-title":"Neurology"},{"issue":"4","key":"1412_CR54","doi-asserted-by":"publisher","first-page":"543","DOI":"10.1016\/j.jalz.2018.12.003","volume":"15","author":"EJ Rogalski","year":"2019","unstructured":"Rogalski EJ, Sridhar J, Martersteck A, Rader B, Cobia D, Arora AK et al (2019) Clinical and cortical decline in the aphasic variant of Alzheimer\u2019s disease. Alzheimers Dement 15(4):543\u2013552","journal-title":"Alzheimers Dement"},{"issue":"12","key":"1412_CR55","doi-asserted-by":"publisher","first-page":"1820","DOI":"10.2967\/jnumed.119.238477","volume":"61","author":"M Rullmann","year":"2020","unstructured":"Rullmann M, McLeod A, Grothe MJ, Sabri O (2020) Barthel H and Alzheimer\u2019s Disease Neuroimaging I, Reshaping the Amyloid Buildup Curve in Alzheimer Disease? Partial-Volume Effect Correction of Longitudinal Amyloid PET Data. J Nucl Med 61(12):1820\u20131824","journal-title":"J Nucl Med"},{"issue":"8","key":"1412_CR56","doi-asserted-by":"publisher","first-page":"964","DOI":"10.1016\/j.jalz.2015.02.004","volume":"11","author":"O Sabri","year":"2015","unstructured":"Sabri O, Sabbagh MN, Seibyl J, Barthel H, Akatsu H, Ouchi Y et al (2015) Florbetaben PET imaging to detect amyloid beta plaques in Alzheimer\u2019s disease: phase 3 study. Alzheimers Dement 11(8):964\u2013974","journal-title":"Alzheimers Dement"},{"key":"1412_CR57","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1016\/j.dadm.2017.06.001","volume":"9","author":"S Salloway","year":"2017","unstructured":"Salloway S, Gamez JE, Singh U, Sadowsky CH, Villena T, Sabbagh MN et al (2017) Performance of [(18)F]flutemetamol amyloid imaging against the neuritic plaque component of CERAD and the current (2012) NIA-AA recommendations for the neuropathologic diagnosis of Alzheimer\u2019s disease. Alzheimers Dement (Amst) 9:25\u201334","journal-title":"Alzheimers Dement (Amst)"},{"issue":"11","key":"1412_CR58","doi-asserted-by":"publisher","first-page":"1116","DOI":"10.1016\/j.jalz.2016.01.003","volume":"12","author":"K Sander","year":"2016","unstructured":"Sander K, Lashley T, Gami P, Gendron T, Lythgoe MF, Rohrer JD et al (2016) Characterization of tau positron emission tomography tracer [18F]AV-1451 binding to postmortem tissue in Alzheimer\u2019s disease, primary tauopathies, and other dementias. Alzheimers Dement 12(11):1116\u20131124","journal-title":"Alzheimers Dement"},{"issue":"4","key":"1412_CR59","doi-asserted-by":"publisher","first-page":"813","DOI":"10.1016\/j.neuroscience.2004.08.050","volume":"130","author":"C Schmitz","year":"2005","unstructured":"Schmitz C, Hof PR (2005) Design-based stereology in neuroscience. Neuroscience 130(4):813\u2013831","journal-title":"Neuroscience"},{"issue":"1","key":"1412_CR60","doi-asserted-by":"publisher","first-page":"181","DOI":"10.3233\/JAD-180749","volume":"67","author":"CG Schwarz","year":"2019","unstructured":"Schwarz CG, Gunter JL, Lowe VJ, Weigand S, Vemuri P, Senjem ML et al (2019) A comparison of partial volume correction techniques for measuring change in serial amyloid PET SUVR. J Alzheimers Dis 67(1):181\u2013195","journal-title":"J Alzheimers Dis"},{"issue":"4","key":"1412_CR61","doi-asserted-by":"publisher","first-page":"518","DOI":"10.1109\/TMI.2006.887364","volume":"26","author":"F Segonne","year":"2007","unstructured":"Segonne F, Pacheco J, Fischl B (2007) Geometrically accurate topology-correction of cortical surfaces using nonseparating loops. IEEE Trans Med Imaging 26(4):518\u2013529","journal-title":"IEEE Trans Med Imaging"},{"issue":"7","key":"1412_CR62","doi-asserted-by":"publisher","first-page":"1019","DOI":"10.1038\/s41374-019-0202-4","volume":"99","author":"M Signaevsky","year":"2019","unstructured":"Signaevsky M, Prastawa M, Farrell K, Tabish N, Baldwin E, Han N et al (2019) Artificial intelligence in neuropathology: deep learning-based assessment of tauopathy. Lab Invest 99(7):1019\u20131029","journal-title":"Lab Invest"},{"issue":"Pt 9","key":"1412_CR63","doi-asserted-by":"publisher","first-page":"2372","DOI":"10.1093\/brain\/aww163","volume":"139","author":"R Smith","year":"2016","unstructured":"Smith R, Puschmann A, Scholl M, Ohlsson T, van Swieten J, Honer M et al (2016) 18F-AV-1451 tau PET imaging correlates strongly with tau neuropathology in MAPT mutation carriers. Brain 139(Pt 9):2372\u20132379","journal-title":"Brain"},{"issue":"3","key":"1412_CR64","doi-asserted-by":"publisher","first-page":"310","DOI":"10.1001\/jamaneurol.2018.3692","volume":"76","author":"R Smith","year":"2019","unstructured":"Smith R, Wibom M, Pawlik D, Englund E, Hansson O (2019) Correlation of in vivo [18F]Flortaucipir with postmortem alzheimer disease tau pathology. JAMA Neurol 76(3):310\u2013317","journal-title":"JAMA Neurol"},{"issue":"11","key":"1412_CR65","doi-asserted-by":"publisher","first-page":"3477","DOI":"10.1093\/brain\/awaa276","volume":"143","author":"DN Soleimani-Meigooni","year":"2020","unstructured":"Soleimani-Meigooni DN, Iaccarino L, La Joie R, Baker S, Bourakova V, Boxer AL et al (2020) 18F-flortaucipir PET to autopsy comparisons in Alzheimer\u2019s disease and other neurodegenerative diseases. Brain 143(11):3477\u20133494","journal-title":"Brain"},{"key":"1412_CR66","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1016\/j.neuroimage.2014.11.058","volume":"107","author":"Y Su","year":"2015","unstructured":"Su Y, Blazey TM, Snyder AZ, Raichle ME, Marcus DS, Ances BM et al (2015) Partial volume correction in quantitative amyloid imaging. Neuroimage 107:55\u201364","journal-title":"Neuroimage"},{"issue":"1","key":"1412_CR67","doi-asserted-by":"publisher","first-page":"2173","DOI":"10.1038\/s41467-019-10212-1","volume":"10","author":"Z Tang","year":"2019","unstructured":"Tang Z, Chuang KV, DeCarli C, Jin LW, Beckett L, Keiser MJ et al (2019) Interpretable classification of Alzheimer\u2019s disease pathologies with a convolutional neural network pipeline. Nat Commun 10(1):2173","journal-title":"Nat Commun"},{"issue":"1","key":"1412_CR68","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1002\/acn3.51238","volume":"8","author":"SJ Teipel","year":"2021","unstructured":"Teipel SJ, Temp AGM, Levin F, Dyrba M (2021) Grothe MJ and Alzheimer\u2019s Disease Neuroimaging I, Association of PET-based stages of amyloid deposition with neuropathological markers of Abeta pathology. Ann Clin Transl Neurol 8(1):29\u201342","journal-title":"Ann Clin Transl Neurol"},{"issue":"12","key":"1412_CR69","doi-asserted-by":"publisher","first-page":"1791","DOI":"10.1212\/WNL.58.12.1791","volume":"58","author":"DR Thal","year":"2002","unstructured":"Thal DR, Rub U, Orantes M, Braak H (2002) Phases of A beta-deposition in the human brain and its relevance for the development of AD. Neurology 58(12):1791\u20131800","journal-title":"Neurology"},{"key":"1412_CR70","unstructured":"Weintraub S and Mesulam M-M, Mental state assessment of young and elderly adults in behavioral neurology, in Principles of behavioral neurology. 1985, F.A. Davis: Philadelphia."},{"issue":"5","key":"1412_CR71","doi-asserted-by":"publisher","first-page":"408","DOI":"10.1177\/1533317509343104","volume":"24","author":"S Weintraub","year":"2009","unstructured":"Weintraub S, Mesulam MM, Wieneke C, Rademaker A, Rogalski EJ, Thompson CK (2009) The northwestern anagram test: measuring sentence production in primary progressive aphasia. Am J Alzheimers Dis Other Demen 24(5):408\u2013416","journal-title":"Am J Alzheimers Dis Other Demen"},{"issue":"1\u20132","key":"1412_CR72","doi-asserted-by":"publisher","first-page":"67","DOI":"10.1155\/2013\/253780","volume":"26","author":"S Weintraub","year":"2013","unstructured":"Weintraub S, Rogalski E, Shaw E, Sawlani S, Rademaker A, Wieneke C et al (2013) Verbal and nonverbal memory in primary progressive aphasia: the Three Words-Three Shapes Test. Behav Neurol 26(1\u20132):67\u201376","journal-title":"Behav Neurol"},{"issue":"11","key":"1412_CR73","doi-asserted-by":"publisher","first-page":"1398","DOI":"10.1001\/archneurol.2011.153","volume":"68","author":"DA Wolk","year":"2011","unstructured":"Wolk DA, Grachev ID, Buckley C, Kazi H, Grady MS, Trojanowski JQ et al (2011) Association between in vivo fluorine 18-labeled flutemetamol amyloid positron emission tomography imaging and in vivo cerebral cortical histopathology. Arch Neurol 68(11):1398\u20131403","journal-title":"Arch Neurol"},{"issue":"6","key":"1412_CR74","doi-asserted-by":"publisher","first-page":"913","DOI":"10.2967\/jnumed.109.069088","volume":"51","author":"DF Wong","year":"2010","unstructured":"Wong DF, Rosenberg PB, Zhou Y, Kumar A, Raymont V, Ravert HT et al (2010) In vivo imaging of amyloid deposition in Alzheimer disease using the radioligand 18F-AV-45 (florbetapir [corrected] F 18). J Nucl Med 51(6):913\u2013920","journal-title":"J Nucl Med"},{"issue":"2","key":"1412_CR75","doi-asserted-by":"publisher","first-page":"230","DOI":"10.1007\/s11307-012-0583-x","volume":"15","author":"DF Wong","year":"2013","unstructured":"Wong DF, Moghekar AR, Rigamonti D, Brasic JR, Rousset O, Willis W et al (2013) An in vivo evaluation of cerebral cortical amyloid with [18F]flutemetamol using positron emission tomography compared with parietal biopsy samples in living normal pressure hydrocephalus patients. Mol Imaging Biol 15(2):230\u2013237","journal-title":"Mol Imaging Biol"},{"issue":"6","key":"1412_CR76","doi-asserted-by":"publisher","first-page":"666","DOI":"10.1016\/j.jalz.2012.11.008","volume":"9","author":"CF Xia","year":"2013","unstructured":"Xia CF, Arteaga J, Chen G, Gangadharmath U, Gomez LF, Kasi D et al (2013) [(18)F]T807, a novel tau positron emission tomography imaging agent for Alzheimer\u2019s disease. Alzheimers Dement 9(6):666\u2013676","journal-title":"Alzheimers Dement"}],"container-title":["Acta Neuropathologica Communications"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s40478-022-01412-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s40478-022-01412-w\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s40478-022-01412-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,11,17]],"date-time":"2022-11-17T04:41:47Z","timestamp":1668660107000},"score":1,"resource":{"primary":{"URL":"https:\/\/actaneurocomms.biomedcentral.com\/articles\/10.1186\/s40478-022-01412-w"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,8,9]]},"references-count":76,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2022,12]]}},"alternative-id":["1412"],"URL":"https:\/\/doi.org\/10.1186\/s40478-022-01412-w","relation":{},"ISSN":["2051-5960"],"issn-type":[{"value":"2051-5960","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,8,9]]},"assertion":[{"value":"24 May 2022","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"17 July 2022","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"9 August 2022","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Northwestern\u2019s Institutional Review Board approved the study and written informed consent was obtained.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"The authors have no relevant financial interest in this article.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"111"}}